Immunotherapy of autoimmune disorders using antibodies which target Bcells

Details for Australian Patent Application No. 2005220212 (hide)

Owner Immunomedics, Inc.

Inventors Hansen, Hans J.; Goldenberg, David M.

Agent Davies Collison Cave

Pub. Number AU-B-2005220212

Parent 782160

Filing date 6 October 2005

Wipo publication date 3 November 2005

Acceptance publication date 11 December 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

20 October 2005 Complete Application Filed

3 November 2005 Application Open to Public Inspection

  Published as AU-B-2005220212

11 December 2008 Application Accepted

  Published as AU-B-2005220212

9 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005220213-Method and apparatus for mapping the trajectory in the subsurface of a borehole

2005220211-Immunotherapy of autoimmune disorders using antibodies which target Bcells